BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24606124)

  • 1. Runx1-mediated regulation of osteoclast differentiation and function.
    Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
    Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx1 Regulates Myeloid Precursor Differentiation Into Osteoclasts Without Affecting Differentiation Into Antigen Presenting or Phagocytic Cells in Both Males and Females.
    Paglia DN; Yang X; Kalinowski J; Jastrzebski S; Drissi H; Lorenzo J
    Endocrinology; 2016 Aug; 157(8):3058-69. PubMed ID: 27267711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
    Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
    Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually Dimorphic Increases in Bone Mass Following Tissue-specific Overexpression of Runx1 in Osteoclast Precursors.
    Díaz-Hernández ME; Kinter CW; Watson SR; Mella-Velazquez G; Kaiser J; Liu G; Khan NM; Roberts JL; Lorenzo J; Drissi H
    Endocrinology; 2022 Sep; 163(9):. PubMed ID: 35880727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation.
    Tang J; Xie J; Chen W; Tang C; Wu J; Wang Y; Zhou XD; Zhou HD; Li YP
    J Biol Chem; 2020 Aug; 295(33):11669-11681. PubMed ID: 32571873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
    Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
    Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.
    Vives V; Laurin M; Cres G; Larrousse P; Morichaud Z; Noel D; Côté JF; Blangy A
    J Bone Miner Res; 2011 May; 26(5):1099-110. PubMed ID: 21542010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
    Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
    J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
    Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
    J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
    Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
    Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function.
    Tsang K; Liu H; Yang Y; Charles JF; Ermann J
    Bone; 2019 Apr; 121():172-180. PubMed ID: 30659979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.
    Yeo H; Beck LH; Thompson SR; Farach-Carson MC; McDonald JM; Clemens TL; Zayzafoon M
    J Biol Chem; 2007 Nov; 282(48):35318-27. PubMed ID: 17884821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
    Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
    Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.